Orbiepharm

company

About

Orbiepharm is a pet medicine and western medicine research and development company.

  • 11 - 50

Details

Last Funding Type
Series B
Last Funding Money Raised
¥20M
Industries
Health Care,Medical,Pet
Founded date
Feb 4, 2010
Number Of Employee
11 - 50
Operating Status
Active

Funding Rounds

Number of Funding Rounds
Total Funding Amount
4
¥110M
Orbiepharm has raised a total of ¥110M in funding over 2 rounds. Their latest funding was raised on Nov 12, 2018 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 12, 2018 Series Unknown ¥50M 1 Jianxinjinyuan Detail
Jun 20, 2016 Series C ¥30M 1 Detail
Dec 25, 2015 Series B ¥20M 1 Shanghai Fangyu Touzi Guanli Zhongxin Detail
Mar 17, 2014 Series A ¥10M 1 Detail

Investors

Number of Lead Investors
Number of Investors
2
4
Orbiepharm is funded by 4 investors. Jianxinjinyuan and Shanghai Fangyu Touzi Guanli Zhongxin are the most recent investors.
Investor Name Lead Investor Funding Round
Jianxinjinyuan Yes Series Unknown
Shanghai Fangyu Touzi Guanli Zhongxin Yes Series B
Huaqing Bencao Investment Management Series C
Baichuan Huida Touzi Series A